Cash flow Revium Rx.

Stocks

RVRC

US76151C1009

Market Closed - OTC Markets 10:43:00 2025-08-05 EDT			5-day change	1st Jan Change
0.5200 ^USD	+73.33%		-.--%	+175.00%

08-13	Revium Rx. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
06-22	Revium Rx. Announces Resignation of Inna Martin from Director, Chief Operating Officer and President, Effective June 16, 2026	CI

616ebc5723b1b023934ff1a39f2997b1.P5vZ299zdmjUHWJszuR8MH-5p3ApXzHzjjSEXPAJTs0.bPOrmrYCMRmATgoLh5I9BCnNxThGJwal5XbxapVLA4xP0Yay7ywgOaN0Ow

Published financial data: REVIUM RX.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Selling General & Admin Expenses, Total	1.12M	673K	1.41M	1.82M
R&D Expenses	67K	7K	2.16M	1.64M
Other Operating Expenses, Total	1.19M	680K	3.57M	3.46M
Operating Income	-1.19M	-680K	-3.57M	-3.46M
Interest Expense, Total	-22K	-3K	-2K	-
Interest And Investment Income	-	-	65K	57K
Net Interest Expenses	-22K	-3K	63K	57K
EBT, Excl. Unusual Items	-1.21M	-683K	-3.5M	-3.41M
Impairment of Goodwill	-	-	-	-8.65M
Asset Writedown	-	-	-	-1.04M
EBT, Incl. Unusual Items	-1.21M	-683K	-3.5M	-13.09M
Income Tax Expense	-	-	-	358K
Earnings From Continuing Operations	-1.21M	-683K	-3.5M	-13.45M
Net Income to Company	-1.21M	-683K	-3.5M	-13.45M
Net Income - (IS)	-1.21M	-683K	-3.5M	-13.45M
Preferred Dividend and Other Adjustments	-	-	-1.42M	-
Net Income to Common Incl Extra Items	-1.21M	-683K	-2.08M	-13.45M
Net Income to Common Excl. Extra Items	-1.21M	-683K	-2.08M	-13.45M
Per Share Items
Net EPS - Basic	-0.04	-0.02	-0.03	-0.22
Basic EPS - Continuing Operations	-0.04	-0.02	-0.03	-0.22
Basic Weighted Average Shares Outstanding	28.11M	29.36M	60.73M	60.73M
Net EPS - Diluted	-0.04	-0.02	-0.03	-0.22
Diluted EPS - Continuing Operations	-0.04	-0.02	-0.03	-0.22
Diluted Weighted Average Shares Outstanding	28.11M	29.36M	60.73M	60.73M
Normalized Basic EPS	-0.03	-0.01	-0.04	-0.04
Normalized Diluted EPS	-0.03	-0.01	-0.04	-0.04
Supplemental Items
EBITDA	-1.19M	-678K	-3.56M	-3.46M
EBITA	-1.19M	-680K	-3.57M	-3.46M
EBIT	-1.19M	-680K	-3.57M	-3.46M
Effective Tax Rate - (Ratio)	-	-	-	-2.73
Normalized Net Income	-758K	-427K	-2.19M	-2.13M
Non-Cash Pension Expense	1K	1K	16K	49K
Supplemental Operating Expense Items
General and Administrative Expenses	1.12M	673K	1.41M	1.82M
Research And Development Expense From Footnotes	67K	7K	2.16M	1.64M
Stock-Based Comp., R&D Exp. (Total)	-	-	1.42M	103K
Stock-Based Comp., G&A Exp. (Total)	292K	45K	580K	521K
Total Stock-Based Compensation	292K	45K	2M	624K

Fiscal Period: December	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Assets
Cash And Equivalents	426K	530K	3.27M	1.68M
Short Term Investments	-	4.95M	2.01M	1.03M
Total Cash And Short Term Investments	426K	5.48M	5.28M	2.71M
Other Receivables	11K	11K	44K	65K
Total Receivables	11K	11K	44K	65K
Prepaid Expenses	20K	37K	171K	284K
Other Current Assets, Total	-	100K	23K	35K
Total Current Assets	457K	5.63M	5.52M	3.1M
Net Property Plant And Equipment	3K	2K	9K	129K
Goodwill	-	-	11.41M	2.58M
Other Intangibles, Total	-	-	3.34M	2.5M
Total Assets	460K	5.63M	20.28M	8.3M
Liabilities
Accounts Payable, Total	50K	64K	142K	163K
Accrued Expenses, Total	-	-	214K	557K
Short-term Borrowings	1K	1K	1K	1K
Current Portion of Leases	-	-	-	55K
Deferred Tax Liability Current	-	-	217K	575K
Other Current Liabilities	19K	79K	2K	18K
Total Current Liabilities	70K	144K	576K	1.37M
Long-Term Leases	-	-	-	46K
Total Liabilities	70K	144K	576K	1.42M
Common Stock, Total	28K	34K	61K	61K
Additional Paid In Capital	5M	10.78M	30.39M	31.78M
Retained Earnings	-4.64M	-5.32M	-11.51M	-24.96M
Total Common Equity	390K	5.49M	18.94M	6.88M
Minority Interest	-	-	770K	-
Total Equity	390K	5.49M	19.71M	6.88M
Total Liabilities And Equity	460K	5.63M	20.28M	8.3M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	28.11M	57.93M	60.73M	61.32M
ECS Total Common Shares Outstanding	28.11M	34.76M	60.73M	60.73M
Book Value / Share	0.01	0.16	0.31	0.11
Tangible Book Value	390K	5.49M	4.18M	1.81M
Tangible Book Value Per Share	0.01	0.16	0.07	0.03
Total Debt	1K	1K	1K	102K
Net Debt	-425K	-5.48M	-5.28M	-2.61M
Minority Interest, Total (Incl. Fin. Div)	-	-	770K	-
Account Code - Inventory Valuation	-	3	3	3
Full Time Employees	-	3	3	3
Part Time Employees	-	3	4	3

Fiscal Period: December	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Net Income	-1.21M	-683K	-3.5M	-13.45M
Depreciation & Amortization - CF	2K	2K	4K	6K
Depreciation & Amortization, Total	2K	2K	4K	6K
Asset Writedown & Restructuring Costs	-	-	-	9.68M
Stock-Based Compensation (CF)	292K	45K	2M	624K
Other Operating Activities, Total	62K	-	-4K	368K
Change In Accounts Payable	-4K	14K	27K	21K
Change in Other Net Operating Assets	40K	-7K	268K	215K
Cash from Operations	-821K	-629K	-1.21M	-2.53M
Capital Expenditure	-2K	-1K	-3K	-7K
Cash Acquisitions	-	-	729K	-
Investment in Marketable and Equity Securities, Total	-	-4.95M	-2M	975K
Other Investing Activities, Total	-	-	-	-27K
Cash from Investing	-2K	-4.95M	-1.27M	941K
Issuance of Common Stock	375K	5.68M	3K	-
Cash from Financing	375K	5.68M	3K	-
Net Change in Cash	-448K	104K	-2.48M	-1.59M
Supplemental Items
Levered Free Cash Flow	-	-424K	303K	-950K
Unlevered Free Cash Flow	-	-422K	304K	-950K
Change In Net Working Capital	-	43K	-534K	-592K

Fiscal Period: December	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Profitability
Return on Assets	-	-13.96	-20.42	-15.15
Return on Total Capital	-	-14.46	-21.14	-16.22
Return On Equity %	-	-23.25	-33.23	-101.17
Return on Common Equity	-	-23.25	-20.5	-104.19
Short Term Liquidity
Current Ratio	6.53	39.08	9.58	2.26
Quick Ratio	6.24	38.13	9.24	2.03
Operating Cash Flow to Current Liabilities	-11.73	-4.37	-2.1	-1.85
Long Term Solvency
Total Debt/Equity	0.26	0.02	0	1.48
Total Debt / Total Capital	0.26	0.02	0	1.46
LT Debt/Equity	-	-	-	0.67
Long-Term Debt / Total Capital	-	-	-	0.66
Total Liabilities / Total Assets	15.22	2.56	2.84	17.06
EBIT / Interest Expense	-54.14	-226.67	-1.78K	-
EBITDA / Interest Expense	-54.05	-226	-1.78K	-
(EBITDA - Capex) / Interest Expense	-54.14	-226.33	-1.78K	-
Total Debt / EBITDA	-0	-0	-0	-0.03
Net Debt / EBITDA	0.36	8.08	1.48	0.75
Total Debt / (EBITDA - Capex)	-0	-0	-0	-0.03
Net Debt / (EBITDA - Capex)	0.36	8.07	1.48	0.75
Growth Over Prior Year
EBITDA, 1 Yr. Growth %	-	-42.98	256.04	-2.97
EBITA, 1 Yr. Growth %	-	-42.91	256.09	-2.91
EBIT, 1 Yr. Growth %	-	-42.91	256.09	-2.91
Earnings From Cont. Operations, 1 Yr. Growth %	-	-43.69	255.12	283.71
Net Income, 1 Yr. Growth %	-	-43.69	255.12	283.71
Normalized Net Income, 1 Yr. Growth %	-	-43.69	255.12	-2.8
Diluted EPS Before Extra, 1 Yr. Growth %	-	-46.09	-	61.96
Net Property, Plant and Equip., 1 Yr. Growth %	-	-33.33	350	1.33K
Total Assets, 1 Yr. Growth %	-	1.12K	1.2K	-59.1
Tangible Book Value, 1 Yr. Growth %	-	1.31K	200.29	-56.72
Common Equity, 1 Yr. Growth %	-	1.31K	1.26K	-63.66
Cash From Operations, 1 Yr. Growth %	-	-23.39	19.43	109
Capital Expenditures, 1 Yr. Growth %	-	-50	0	133.33
Levered Free Cash Flow, 1 Yr. Growth %	-	-	-145.99	-413.79
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-	-146.18	-412.5
Compound Annual Growth Rate Over Two Years
EBITDA, 2 Yr. CAGR %	-	-	73.13	85.86
EBITA, 2 Yr. CAGR %	-	-	73.08	85.93
EBIT, 2 Yr. CAGR %	-	-	73.08	85.93
Earnings From Cont. Operations, 2 Yr. CAGR %	-	-	69.99	269.14
Net Income, 2 Yr. CAGR %	-	-	69.99	269.14
Normalized Net Income, 2 Yr. CAGR %	-	-	69.99	85.79
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	-10.82	-
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-	73.21	703.12
Total Assets, 2 Yr. CAGR %	-	-	564.01	130.68
Tangible Book Value, 2 Yr. CAGR %	-	-	227.38	14
Common Equity, 2 Yr. CAGR %	-	-	596.81	122.33
Cash From Operations, 2 Yr. CAGR %	-	-	21.45	57.99
Capital Expenditures, 2 Yr. CAGR %	-	-	22.47	52.75
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-	20.13
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	-	20.13
Compound Annual Growth Rate Over Three Years
EBITDA, 3 Yr. CAGR %	-	-	-	42.74
EBITA, 3 Yr. CAGR %	-	-	-	42.74
EBIT, 3 Yr. CAGR %	-	-	-	42.74
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	-	122.99
Net Income, 3 Yr. CAGR %	-	-	-	122.99
Normalized Net Income, 3 Yr. CAGR %	-	-	-	41.09
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-	72.49
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	-	250.34
Total Assets, 3 Yr. CAGR %	-	-	-	162.24
Tangible Book Value, 3 Yr. CAGR %	-	-	-	66.77
Common Equity, 3 Yr. CAGR %	-	-	-	160.33
Cash From Operations, 3 Yr. CAGR %	-	-	-	45.54
Capital Expenditures, 3 Yr. CAGR %	-	-	-	51.83